CV
CVS Group plc
CVSGF · OTC
$16.60 +0.00% (+$0.00)
Market Cap £853.6M
P/E Ratio 16.17x
Div. Yield 0.67%
ROE 18.92%
Bulios Fair Price
$20.56
23.9% upside
Current Price
$16.6
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CVSGF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
92 /100
Cheap P/E 16.17x
PEG 0.02x
EV/EBITDA 6.88x
Growth
71 /100
Growing EPS growth 0.92%
Book val. growth 11.31%
Rev. growth 18.58%
Profitability
54 /100
Moderate Gross margin 38.58%
FCF margin 8.27%
Net margin 5.71%
Quality
62 /100
Average ROIC 7.20%
Asset turnover 0.97x
ROE 18.92%
Debt
54 /100
Moderate Debt/Equity 0.83x
Net debt/EBITDA 2.04x
Current ratio 1.10x
Stability
52 /100
Moderate Beta 1.07x
Profitable years 6
Rev. volatility 20.11%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CVSGF
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Richard William Mark Fairman
Employees
9,000
Headquarters
Diss
Upcoming events
24 SEP
Earnings
Upcoming earnings report